Impact of disease activity and cumulative damage on the health of lupus patients

Abstract

To test if lupus activity and damage predict physical function and general health in lupus was the objective of this study. Ninety-six patients with lupus were seen at baseline and monthly for 4 months. Sociodemographic characteristics and lupus damage (SLICC/ACR DI), were collected at baseline while lupus activity (SLAM-R, SLEDAI), health status measures (HAQ, SF-36^TM) and immunological tests were collected at each visit. Associations of lupus activity and damage with general health and physical function were evaluated. Baseline health status measures were greatly impaired and comparable to those of severe medical illnesses. In cross-sectional analyses, baseline activity score measured by SLAM-R, but not by SLEDAI, correlated with most subscales of SF-36^TM. Baseline damage score SLICC ACR DI correlated only with the HAQ and the physical function subscale of SF-36^TM. Differences in both activity measures (SLAM-R and SLEDAI) over time correlated with change in health status measures while baseline cumulative damage (SLICC/ACR DI) correlated with the average level of physical function only. Lupus activity measures, SLAM-R and SLEDAI, although differing cross-sectionally, both reflected patients' health status performance over time and lupus damage measure, SLICC/ACR DI, performed well in assessing physical function. Lupus patients scores for health are poor and comparable to those found in severe medical illnesses.

Keywords

health status physical function activity damage

Get full access to this article

View all access options for this article.

References

Gladman DD , Urowitz MB . Morbidity in systemic lupus erythematosus . J Rheumatol 1987; 14 (Suppl. 13): 223–226 .

Ginzler E , Berg A . Mortality in systemic lupus erythematosus . J Rheumatol 1987; 14 (Suppl. 13): 218–264 .

Abu-Shakra M , Urowitz MB , Gladman DD , Gough J . Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death . J Rhematol 1995; 22: 1259–1264 .

Stein H , Walters K , Dillon A , Schulzer M . Systemic Lupus Erythematosus: a medical and social profile . J Rheumatol 1986; 13: 570–576 .

Karlson EW et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 47–56 .

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

Gladman D et al. The development and initial validation of the SLICC ACR damage index for SLE . Arthritis Rheum 1996; 39: 363–369 .

Fries JF , Spitz PW , Young DY . The Dimensions of Health Outcomes: the Health Assessment Questionnaire, Disability and Pain Scales . J Rheumatol 1982; 9: 789–793 .

Ware JE Jr , Sherbourne CD . The MOS 36-Item short-form health survey (SF-36). I. Conceptual Framework and item selection . Medical Care 1992; 30: 473–483 .

10.

Liang MH , Socher SA , Larson MG , Schur PH . Reliability and validity of six systems for the clinical assessment of disease activity in SLE . Arthritis Rheum 1989; 32: 1107–1118 .

11.

Bombardier C et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35: 630–640 .

12.

Fortin PR , Abrahamowicz M , Danoff DD . Small changes in out-patient lupus activity are better detected by clinical instruments than by laboratory tests . J Rheum 1995; 22: 2078–2083 .

13.

Gary NC . SAS Institute (1990). SAS STAT user's guide. Version 6, 4th edn vol. 2.

14.

Jennrich RI , Schluchter MD . Unbalanced repeated-measures models with structured covariance matrices . Biometrics 1986; 42: 805–820 .

15.

BMDP-5V . Statistical Software Manual, vol. 2, 1990. Berkeley: University of California Press .

16.

Akaike H . A new look at the significant model identification . IEEE Trans Automat Control 1974; 19: 716–723 .

17.

McHorney CA , Ware JE Jr , Raczek AE . The MOS 36-Item Short-Form Health Survey (SF-36): II: Psychometric and clinical tests of validity in measuring physical and mental health constructs . Medical Care 1993; 31: 247–263 .

18.

Gladman DD , Urowitz MB , Ong A , Gough OJ , MacKinnon A . Lack of correlation among the three outcomes describing SLE: disease activity, damage and quality of life . Clin Exp Rheumatol 1996; 14: 305–308 .

19.

Abrahamowicz M et al. The relationship between disease activity and physician's decision to start treatment in active systemic lupus erythematosus . J Rheumatol 1998; 25; 277–284 .

20.

Stoll T et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 1608–1614 .